https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-29 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Jan;73(1):128-35
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-29 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Jan;73(1):128-352008-05-29 00:00:002019-02-15 08:34:59Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-20 / Vaccine 2008 Jul;26(29-30):3735-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-20 / Vaccine 2008 Jul;26(29-30):3735-412008-05-20 00:00:002019-02-15 09:15:04Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-17 / Cancer Immunol. Immunother. 2009 Jan;58(1):61-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-17 / Cancer Immunol. Immunother. 2009 Jan;58(1):61-92008-05-17 00:00:002021-11-15 17:04:52Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-15 / Cancer Res. 2008 May;68(10):3854-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-15 / Cancer Res. 2008 May;68(10):3854-622008-05-15 00:00:002008-05-15 00:00:00Cancer immunotherapy using in vitro genetically modified targeted dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-15 / Gene Ther. 2008 Oct;15(19):1321-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-15 / Gene Ther. 2008 Oct;15(19):1321-92008-05-15 00:00:002019-02-15 09:19:21Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-15 / Clin. Cancer Res. 2008 May;14(10):3098-104
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-15 / Clin. Cancer Res. 2008 May;14(10):3098-1042008-05-15 00:00:002021-11-15 14:47:03Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-01 / Rev Recent Clin Trials 2008 May;3(2):121-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-01 / Rev Recent Clin Trials 2008 May;3(2):121-52008-05-01 00:00:002019-02-15 09:23:43Immunotherapy of pancreatic carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-01 / J. Immunother. 2008 May;31(4):402-12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-01 / J. Immunother. 2008 May;31(4):402-122008-05-01 00:00:002019-02-15 09:19:31Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-01 / J. Immunother. 2008 May;31(4):345-58
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-01 / J. Immunother. 2008 May;31(4):345-582008-05-01 00:00:002019-02-15 09:19:30Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-01 / Eur. J. Immunol. 2008 May;38(5):1310-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-01 / Eur. J. Immunol. 2008 May;38(5):1310-202008-05-01 00:00:002019-02-15 09:15:05Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine
